Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow LEMAITRE VASCULAR INC

Get SEC filing alerts via email and in your feed for LEMAITRE VASCULAR INC

LMAT

LEMAITRE VASCULAR INC

About LEMAITRE VASCULAR INC

LeMaitre Vascular is a global provider of medical devices and human tissue cryopreservation services for treating vascular, renal, and cardiovascular diseases. Its product portfolio includes biologic patches, grafts, shunts, and surgical closure systems used primarily in open vascular surgeries. The company serves vascular surgeons and related specialists worldwide, leveraging a direct sales force and strategic acquisitions to maintain a competitive edge in niche markets.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from LEMAITRE VASCULAR INC

1
1
LEMAITRE VASCULAR INC LeMaitre Vascular Reports 11% Net Sales Increase to $66.6 Million in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
LEMAITRE VASCULAR INC LeMaitre Vascular Reports 14% Revenue Growth to $249.6 Million for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
LEMAITRE VASCULAR INC LeMaitre Vascular Reports 11% Revenue Growth in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
LEMAITRE VASCULAR INC LeMaitre Vascular Reports 15% Revenue Growth to $64.2 Million in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
LEMAITRE VASCULAR INC LeMaitre Vascular Reports 12% Net Sales Increase to $59.9 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
LEMAITRE VASCULAR INC LeMaitre Vascular Reports 14% Increase in Net Sales to $219.9 Million for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
LEMAITRE VASCULAR INC LeMaitre Vascular Reports 16% Revenue Growth, Net Income Increase in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments